Our News on Newswise

Newswise: /images/uploads/2022/07/26/62e0a54ecf262_Vitelliformmaculardystrophyfundusphoto.jpg

High-Tech Imaging Reveals Details About Rare Eye Disorder

Using a new imaging technique, researchers from the National Eye Institute have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing effective treatments...
26-Jul-2022 10:05 PM EDT Add to Favorites

Newswise: 62d5c7a5a7367_Serpin1-lipid.png

NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye

Loss of the protein pigment epithelium-derived factor (PEDF), which protects retinal support cells, may drive age-related changes in the retina, according to a new study in mice from the National Eye Institute (NEI).
18-Jul-2022 4:55 PM EDT Add to Favorites

Newswise: 62cc71cad2164_image1.jpeg

A type of ‘step therapy’ is an effective strategy for diabetic eye disease

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve...
11-Jul-2022 3:40 PM EDT Add to Favorites

Newswise: 62c5ea68a23de_pahlbergillustrationv3small.png

NIH Researchers Decode Retinal Circuits for Circadian Rhythm, Pupillary Light Response

The eye’s light-sensing retina taps different circuits depending on whether it is generating image-forming vision or carrying out a non-vision function such as regulating pupil size or sleep/wake cycles, according to a new mouse study from the...
6-Jul-2022 4:20 PM EDT Add to Favorites

Gene Therapy for Rare Eye Disease Safe but Lacks Efficacy in Early Trial

Byron Lam and collaborators at the University of Miami reported results from an 8-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy. They found no significant safety concerns; however,...
7-Jun-2022 5:05 PM EDT Add to Favorites

NIH study confirms benefit of supplements for slowing age-related macular degeneration

The AREDS2 dietary supplement formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original AREDS formula.
2-Jun-2022 12:20 PM EDT Add to Favorites

Retinal Cell Map Could Advance Precise Therapies for Blinding Diseases

Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) discovered five subpopulations of retinal pigment...
6-May-2022 3:50 PM EDT Add to Favorites

Newswise: 62616a7b35d21_eyeschematicRVOv2-02.png

Vision improvement is long-lasting with treatment for blinding blood vessel condition

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ongoing treatment.
21-Apr-2022 10:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

NEI Highlights Cell and Gene Therapies, Novel Imaging Technologies at Vision Research Meeting

The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016).
29-Apr-2016 10:05 AM EDT

Hopkins Vision Researcher Links Environmental Change to Eye Health Hazards

Another reason to worry about climate change: Expanding areas of arid land, air pollution, and greater exposure to ultraviolet (UV) radiation all present potential health hazards to your eyes, according to Sheila West, Ph.D., vice chair for research...
8-Dec-2015 3:30 PM EST

Dr. Emily Chew of #NIH Is Available to Talk About Macular Degeneration

21-Apr-2015 11:05 AM EDT

See All Experts

Our YouTube Videos

About

As part of the federal government's National Institutes of Health (NIH), the National Eye Institute's mission is to conduct and support research, training, health information dissemination, and other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health problems and requirements of the blind.

Contacts

Dustin Hays
Chief, Science Communications

dustin.hays@nih.gov

301-496-5248

Kathryn DeMott
Science Writer

neinews@nei.nih.gov

301-496-5248

Lesley Earl
Science Writer
vision research

lesley.earl@nih.gov

301-496-5248

Michael Brown

mb459p@nih.gov

3013994074

Claudia Costabile
Public Affairs Specialist

claudia.costabile@nih.gov

301-496-5248

Twitter

close
0.34474